Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
This guide compares risk levels between bonds and stocks in retirement, outlining factors like market cycles, duration, and income needs.
28,627 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Policy shifts in California could ripple through the multifamily loan market. This guide explains what to watch, how ...
Agentic rising fast AI is changing how businesses operate, not just how we talk to machines. This article analyzes So...
A New Mexico jury awarded Meta $375 million in a landmark ruling over child-safety claims, challenging broad protecti...
Russia is moving to block foreign crypto exchanges unless they comply with new domestic regulations, aiming to funnel...
NVIDIA stakes its AI dominance on data center hardware while Palantir expands software driven growth, setting up a hi...
Meta’s latest move signals a serious push into cloud services. This article breaks down what Mark Zuckerberg's Meta l...
Bitcoin has moved back into a critical zone around $66,900 to $68,000, renewing questions about whether the price wil...
A private-space pioneer with sprawling ambitions is stirring debate about valuation, growth, and risk. This guide bre...
Rushing big personal projects can threaten more than your to-do list. This piece breaks down the MGK case as a money-...
When regulators and exchanges join forces to reverse a settlement, it signals a new chapter in crypto enforcement. Th...
Bitcoin and Ethereum held near major thresholds as weekend clashes between the United States and Iran revived volatil...